Patent ID: 6835748
Filing Date: 2004-12-28
Classification: A61K,A61P

Abstract:
A method of treating an ocular disorder selected from the group consisting of glaucoma, normal tension glaucoma and neurodegenerative disease condition of the retina and the optic nerve, which method comprises the repeated administration to an individual of a pharmaceutically effective amount of a compound of formula (I) whereinR1 is hydrogen, lower alkyl, cyclohexyl, allyl or benzyl, R2 is hydrogen, methyl, ethyl or propyl or R1 and R2 together with the nitrogen to which they are attached form a morpholino or piperidino radical, R3 is hydrogen or lower alkyl, R4 and R5 are the same or different and each is a lower alkyl, and the dialkylaminoalkyl group is in the meta, ortho or para position, in free base or pharmaceutically acceptable acid addition salt form.